THERMO FISHER SCIENTIFIC COM (TMO) : Lathrop Investment Management Corp scooped up 440 additional shares in THERMO FISHER SCIENTIFIC COM during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 92,916 shares of THERMO FISHER SCIENTIFIC COM which is valued at $13,644,715.THERMO FISHER SCIENTIFIC COM makes up approximately 4.30% of Lathrop Investment Management Corp’s portfolio.
THERMO FISHER SCIENTIFIC COM opened for trading at $145.61 and hit $147.7521 on the upside on Wednesday, eventually ending the session at $147.14, with a gain of 1.05% or 1.53 points. The heightened volatility saw the trading volume jump to 14,97,750 shares. Company has a market cap of $58,306 M.
Other Hedge Funds, Including , Boston Advisors boosted its stake in TMO in the latest quarter, The investment management firm added 253 additional shares and now holds a total of 74,751 shares of THERMO FISHER SCIENTIFIC COM which is valued at $10,977,184. THERMO FISHER SCIENTIFIC COM makes up approx 0.27% of Boston Advisors’s portfolio.Firstmerit Bank N A Trustee boosted its stake in TMO in the latest quarter, The investment management firm added 241 additional shares and now holds a total of 48,008 shares of THERMO FISHER SCIENTIFIC COM which is valued at $7,049,975. THERMO FISHER SCIENTIFIC COM makes up approx 0.58% of Firstmerit Bank N A Trustee’s portfolio. Koshinski Asset Management added TMO to its portfolio by purchasing 2,756 company shares during the most recent quarter which is valued at $400,557. THERMO FISHER SCIENTIFIC COM makes up approx 0.26% of Koshinski Asset Management’s portfolio.
On the company’s financial health, THERMO FISHER SCIENTIFIC COM reported $2.12 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jan 28, 2016. Analyst had a consensus of $2.11. The company had revenue of $4652.50 million for the quarter, compared to analysts expectations of $4551.79 million. The company’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.99 EPS.
Many Wall Street Analysts have commented on THERMO FISHER SCIENTIFIC COM. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .Company shares were Reiterated by Topeka Capital Markets on Mar 2, 2016 to “Buy”, Firm has raised the Price Target to $ 155 from a previous price target of $145 .
Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.